MSCI delays its Indonesia equities status decision, and investors are now stuck weighing whether reforms will stick by November.

A few draft slots can mean tens of millions, because NBA TV deals keep inflating the paycheck pool.

Superhuman’s acquisition of GPTZero signals that AI writing tools are racing beyond generation into trust and verification.

Record registrations, 57.5% new-drug studies, and US security pressure on the race to novel pipelines.

A $299-to-$239 Prime Day drop revives a kid-friendly motion console deal, but subscriptions still shape the real cost.

A confidential deal shields YouTube and Google from the July 27 jury, while the next bellwethers continue to pile up.

The satellite and rocket company’s quick $25 billion borrowing move signals how it plans to finance scale after going public.

On Thursday, Accenture hit its biggest one-day drop on record after forecasting worries that AI could hollow out consulting.

CNBC says SpaceX’s shares surge following its IPO Friday, forcing investors to reprice what “space” and “AI” are worth.

Big IPO, bigger options debut: what it means for investors, risk teams, and anyone benchmarking market appetite.

SpaceX exercised its option for Cursor in an all-stock deal worth $60 billion, reshaping AI dealmaking expectations.

The valuation jump of $1T in a single day changes the reference point for risk capital and public-market comps.